Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course-Reference-Cited by-同舟云学术

Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course

Published:2022-11-14 Issue:3 Volume:129 Page:367-375
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Haryal Aneesha¹,Townsend Matthew J.²^ORCID,Baskaran Vinitha¹,Srivoleti Padmavathi¹,Giobbie‐Hurder Anita³,Sack Jordan S.¹⁴,Isidro Raymond A.⁵,LeBoeuf Nicole R.⁴⁶,Buchbinder Elizabeth I.⁴⁷^ORCID,Hodi F. Stephen⁴⁷,Grover Shilpa¹⁴^ORCID

Affiliation:

1. Division of Gastroenterology, Hepatology, and Endoscopy Department of Medicine Brigham and Women's Hospital Boston Massachusetts USA

2. Department of Medicine Duke University Hospital Durham North Carolina USA

3. Division of Biostatistics Department of Data Science Dana‐Farber Cancer Institute Boston Massachusetts USA

4. Harvard Medical School Boston Massachusetts USA

5. Department of Pathology Brigham and Women's Hospital Boston Massachusetts USA

6. Department of Dermatology, Center for Cutaneous Oncology Dana‐Farber/Brigham and Women's Cancer Center Boston Massachusetts USA

7. Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34543

Reference38 articles.

1. Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

2. Severe gastritis due to pembrolizumab treatment in a lung cancer patient

3. Lymphocytic gastritis induced by pembrolizumab in a patient with metastatic melanoma

4. Auto‐immune gastritis induced by pembrolizumab, an anti‐PD‐1, in a melanoma patient;Vandepapelière J;Acta Gastro‐Enterol Belg,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolated Immune Checkpoint Inhibitor-Induced Gastritis Leading to Gastrocolic Fistula Formation;ACG Case Reports Journal;2024-07

2. Immune checkpoint inhibitor-associated gastritis: Patterns and management;World Journal of Gastroenterology;2024-04-14

3. Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors;Alimentary Pharmacology & Therapeutics;2024-04-08

4. Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective;eClinicalMedicine;2024-04

5. Clinical Management of Gastrointestinal and Liver Toxicities of Immune Checkpoint Inhibitors;Clinical Colorectal Cancer;2023-12